Introduction {#sec1-1}
============

Brucellosis is a well-known domestic animal infection which survives within a broad range of eukaryotic cells as a small gram-negative coccobacillus. This disease is characterized by abortion and reduced fertility in animals, and also by chronic infections with symptoms such as undulant fever, arthritis and osteomyelitis in humans ([@ref1]). GroEL gene encodes an inner membrane protein of Brucella with about 60 kDa molecular weight. This protein belongs to heat shock protein family, and as a chaperonin has an important role in the structure and folding of other proteins. In response to macrophage phagocytosis, Brucella produces the GroEL antigen in order to increase its survival. GroEL is one of the major antigens that stimulates the immune system. Furthermore, this antigen has an important role in disease cycle in humans and animals ([@ref2]). In a comparative study on two different strains of Brucella, the HSP (GroEL) antigen was introduced as a good candidate for vaccine production and also development of diagnostic kits ([@ref3]).

Immune system produces antibodies which specifically attach to identified regions of antigens named epitope ([@ref4]). Epitopes may be classified as B (continuous and discontinuous) and T-cell (MHCI and MHCII) epitopes ([@ref5]). The continuous or linear epitopes are made up of consecutive amino acids whereas the discontinuous epitopes constitute the spatially folded amino acids which lie far away in the primary sequence ([@ref6]). T-cell epitopes are antigenic peptide strings recognized by T-cell receptors ([@ref7]). B and T-cell epitopes could be predicted using computational tools for the vast applications in the area of antibody production, immunodiagnostics, epitope-based vaccine design and selective de-immunization of therapeutic proteins and in autoimmunity ([@ref8]). Several epitope prediction software applications are currently available. The first generation of these prediction tools was supported by motif-based algorithms ([@ref9]), antigen's primary amino acid sequence ([@ref10]), or other physiochemical protein characteristics. Recently more sophisticated methods using various machine learning based algorithms have been developed based on support vector machines (SVM) ([@ref11]), hidden markov models (HMM) ([@ref12]), and artificial neural networks (ANN) ([@ref5]).

The aim of the present study was cloning, molecular analysis and epitopes prediction of GroEL antigen from *B. melitensis* strain Rev 1. Finally, B and T-cell epitopes were predicted in order to design an epitope-based vaccine for stimulation of the immune system.

Materials and Methods {#sec1-2}
=====================

Bacterial strains, growth conditions and isolation {#sec2-1}
--------------------------------------------------

In current study, *B. melitensis* strain Rev 1 was obtained from the Brucella culture collection (Razi Institute, Mashhad, Iran) and cultured as described ([@ref13]). DNA was extracted using a DNA extraction kit (Bioneer, Korea). The quality and purity of the extracted DNA were analyzed by agarose gel electrophoresis and NanoDrop ND-1000 spectrophotometer (Thermo, USA). *Escherichia coli* strain DH5α was used as host for cloning, sequencing and maintenance of different DNA fragments. A T/A cloning vector pTZ57R/T (Thermo, USA) was used for cloning and sequencing of the amplified gene.

PCR amplification {#sec2-2}
-----------------

*B. melitensis* Rev 1 genomic DNA was used as template for amplification of full length open reading frame of GroEL gene using *EX Taq* DNA polymerase (Takara, Japan). The specific primers were designed according to the *B*. *melitensis* 16M as template using Primer Premier 5, according to the available nucleotide sequences on the NCBI GenBank database ([Table 1](#T1){ref-type="table"}).

###### 

The specific primers with restriction sites

  Gene                                   Primer sequences (5' → 3')
  -------------------------------------- -------------------------------------
  *GroEL*                                F:5\`-ATGGCTGCAAAAGACGTAAAATTCG-3\`
  R:5\`-TTATTAGAAGTCCATGCCGCCCATGC-3\`   

Polymerase Chain Reaction (PCR) was carried out, using the Personal Cycler™ thermocycler (Biometra, Germany) with the reaction mixture containing 2.5 μl of 10X PCR buffer, 2 μl MgCl~2~ and 2 μl dNTPs, 0.3 μl of the template DNA (50 to 100 ng/μl), 1.5 μl of primer mixture (5 pmol/μl) and 0.125 U/μl of *EX Taq* DNA polymerase, and deionized water up to a final volume of 25 μl. The PCR program was performed with an initial denaturation step at 94 °C for 6 min followed by 27 cycles of denaturation at 94 °C for 30 sec, annealing at 58 °C for 30 sec and extension at 72 °C for 45 sec, and a final extension at 72 °C for 10 min.

Cloning and Nucleotide sequences analysis {#sec2-3}
-----------------------------------------

The PCR products were purified from the agarose gel by Ron's Agarose Gel Mini prep Kit (BioRon, Germany) according to the manufacturer's instructions. The purified PCR products were ligated into pTZ57R/T cloning vector by T/A cloning strategy according to the manufacturer's instructions (Thermo, USA). *Escherichia coli* DH5α competent cell preparation and transformation steps were followed as described by Sambrook and Russell ([@ref14]). The recombinant vectors were transformed into competent *E. coli* DH5α cells. The bacterial clones harboring recombinant plasmid DNA were screened based on their colony PCR and restriction sites enzyme digestion. PCR was used for verification fidelity of *E. coli* DH5α transformants. The plasmids were purified using the Ron's Plasmid Mini Kit (BioRon, Germany) and confirmed by restriction sites enzyme digestion. The purified plasmids were subjected to sequencing using Sanger method (Bioneer, South Korea). The obtained nucleotide sequences were analyzed by homology search and aligning them with other GroEL genes using Basic Local Alignment Search Tool (BLAST), CLC Main workbench 5.5 and MEGA 5 software applications, respectively.

Prediction of the secondary and tertiary structures {#sec2-4}
---------------------------------------------------

The secondary structures of candidate genes were analyzed using the improved self-optimized prediction method (SOPMA) software (<http://npsapbil.ibcp.fr/cgibin/npsa_automat.pl?page=/NPSA/npsa_sopma.html>) ([@ref15]), with predicting four conformational states (helices, sheets, turns and coils). Also, tertiary structures were predicted using online ligand-binding site prediction server (<http://www.sbg.bio.ic.ac.uk>) ([@ref16]).

Servers and software applications for B and T-cell epitopes prediction {#sec2-5}
----------------------------------------------------------------------

B and T-cell epitopes of candidate genes were predicted using different servers and software applications such as: ABCpred, BepiPred, BCPred, SVMTrip and LEPS for B-cell prediction and IEDB, SYFPEITH, PropredI and Propred for T-cell prediction.

Validation bioinformatics analysis approach {#sec2-6}
-------------------------------------------

In order to confirm our predicted outputs, the results of three different experimental epitope prediction studies were validated by bioinformatics tools, which were used in the present study.

Characterization of epitopes {#sec2-7}
----------------------------

Final B and T-cell predicted epitopes were evaluated using the VaxiJen 2.0 server (<http://www.ddg-pharmfac.net/vaxijen/VaxiJen/-VaxiJen.html>) for the alignment-independent prediction of protective antigens. In addition, enzymatic degradation sites, Mass (Da) and pI were determined using the Protein Digest server (<http://db.Systemsbiology.net:8080/proteomicsToolkit/proteinDigest.html>).

Results {#sec1-3}
=======

PCR amplification, cloning and nucleotide sequencing analysis {#sec2-8}
-------------------------------------------------------------

The GroEL gene from *B. melitensis* Rev 1 was amplified. The accuracy of this fragment was visualized on agarose gel electrophoresis ([Figure 1](#F1){ref-type="fig"}).

![PCR amplification of GroEL (1641 bp) gene](IJBMS-18-499-g001){#F1}

The amplified products were successfully ligated into cloning vector and transformed into competent *E. coli* DH5α cells. After the selection of positive screen colonies using colony-PCR, the integrity of the recombinant plasmids were confirmed by restriction digestion. The sequencing of the recombinant plasmids was performed. The obtained sequence was analyzed using BLAST and CLC Main workbench 5.5 software program. This sequence was compared and aligned with other chaperone GroEL sequences in different species. Results showed that this sequence had differences with other bacterium and Brucella species ([Figure 2](#F2){ref-type="fig"}). According to the results of the current study a new sequence from strain *B. melitensis* Rev 1 has been published for the first time on NCBI gene database under accession numbers KJ889017.

![Results of alignment between Brucella melitensis Rev 1 and other Brucella spp. Dark color indicates different nucleotide](IJBMS-18-499-g002){#F2}

Contrary to expectation, the GroEL sequence was found to have near homology with the *Yersinia*, *Salmonella*, *E. coli* and *Xenorhabdus* instead of other *Brucella* spp. ([Figure 3](#F3){ref-type="fig"}).

![Pairwise comparison between candidate gene and other spp](IJBMS-18-499-g003){#F3}

Upper triangle shows percent identity and down triangle shows differences in each matrix.

In addition, the phylogenic tree was drawn for showing the genetic distance matrix results. This showed that *B. melitensis* strain Rev 1 had near homology with *Xenorhabdus*, *Yersinia*, *Salmonella* and *E. coli*, as like as pairwise comparison matrix ([Figure 4](#F4){ref-type="fig"}).

![Phylogenic tree between Brucella melitensis Rev 1 and other Brucella spp](IJBMS-18-499-g004){#F4}

Prediction of the secondary structure {#sec2-9}
-------------------------------------

In order to assess the antigenic features of the candidate protein, its secondary structure was predicted using SOPMA server software. The results revealed that the proportion of random coils, β turns, α helices and extended strands (β folds) accounted for 22.53, 9.52, 55.31 and 12.64% of the secondary structure, respectively. A greater proportion of α helices corresponded with stability and resistance of protein structure ([@ref13]).

Validation bioinformatics analysis approach {#sec2-10}
-------------------------------------------

In order to validate B and T cell prediction software applications used in the present study, three antigens whose epitopes were determined experimentally (<http://www.iedb.org>), were selected and their epitopes were predicted using the bioinformatics tools used in the present study. The predicted epitopes were compared with the results of experimental research. Results revealed that *in sillico* predicted epitopes by bioinformatics tools were similar to those found by experimental studies for all of the selected antigens ([Table 2](#T2){ref-type="table"}).

###### 

Validation of bioinformatics software applications that were used in the present study

  Antigen                                        Predicted epitopes                                           Experimental epitopes   Reference
  ---------------------------------------------- ------------------------------------------------------------ ----------------------- --------------------
  GroEL[1](#t2n1){ref-type="fn"} of *Yarsinia*   28-42,78-92,178-185,275-290,[315-336]{.ul},430-440,526-545   316-326                 [@ref17]
  Dnak[2](#t2n2){ref-type="fn"} of *Brucella*    40-67,78-92,210-227,357-370, 523-537, [609-640]{.ul}         617-637                 [@ref9]
  Omp31[3](#t2n3){ref-type="fn"} of *Brucella*   25-28,[46-73]{.ul},122-127,175-182                           48-74                   [@ref18], [@ref19]
  SOD [4](#t2n4){ref-type="fn"} of *Brucella*    44-50,[70-86,134-153,147-165]{.ul}                           75-86,136-150,149-162   [@ref20]

Heat Shock Protein 60,

Heat Shock Protein 70,

Outer Membrane 31,

Sodium Oxide Dismutase

Similar epitopes between predicted epitopes using bioinformatics tools and experimental studies were emboldened and underlined

Prediction of the B and T-cell epitopes {#sec2-11}
---------------------------------------

The B- cell and MHCI (A-0101, A0201 and B-2705) and MHCII (DRB1-0101 and DRB1-0401) class of T-cell epitope were predicted using different online software applications. For each software the highest score epitopes were selected as appropriate epitopes. Moreover, eight epitopes for B-cell and seven for T-cell were chosen as final epitopes by identifying those epitopes which had the most conserved sequences in all proposed epitopes ([Table 3](#T3){ref-type="table"}).

###### 

Final B and T-cell epitopes after filtration

  No.   Final B-cell epitope             Final T-cell epitope
  ----- -------------------------------- --------------------------------
  1     ~30~ TLGPKGRNVVL ~40~            ~160~ KLIAEAM ~166~
  2     ~150~ ISANSDETVGKLIAEAM ~166~    ~150~ ISANSDETVGKLIAEAM ~166~
  3     ~219~ ILLVDKKISNI ~230~          ~205~ INKPETGSVELENPYILL ~222~
  4     ~270~ IVKVAAVKAP ~279~           ~279~ PGFGDRR ~285~
  5     ~351~ QQIEDSTSDY ~360~           ~351~ QQIEDSTSDYD ~361~
  6     ~385~ TEVEMKEKR ~393~            ~385~ TEVEMKEKRAR ~395~
  7     ~453~ QIVENAGEEPSVVVNTVK ~470~   ~418~ ALVRVAAALTALT ~430~
  8     ~526~ DDKMDLGA ~534~             ~470~ KGGKGNY ~476~

Characterization of epitopes {#sec2-12}
----------------------------

The results of protein digest server analysis for determination of mass (Da), pI and enzymatic degradation site are shown in [Table 4](#T4){ref-type="table"}. Results indicate that most of the predicted epitopes in GroEL were lack of proteasomal cleavage site and no degrade during antigen processing.

###### 

Protein digestion analysis of final B-and T-cell epitopes

  B-cell epitopes                  Mass (Da)   pI     Undigested enzyme
  -------------------------------- ----------- ------ ------------------------------------------------------------------------------------------------------------------------------------------
  ~30~ TLGPKGRNVVL ~40~            1153.39     11.0   Chymotrypsin, Cyanogen Bromide, Iodobenzoate Benzoate, Staph Protease, AspN
  ~150~ ISANSDETVGKLIAEAM ~166~    1748.97     4.1    Chymotrypsin, Proline Endopeptidase, Cyanogen Bromide, Iodobenzoate Benzoate, Clostripain
  ~219~ ILLVDKKISNI ~230~          1255.56     8.6    Trypsin R, Proline Endopeptidase, Cyanogen Bromide, Clostripain, Iodobenzoate Benzoate, Staph Protease, Chymotrypsin
  ~270~ IVKVAAVKAP ~279~           995.27      10.0   Chymotrypsin, Proline Endopeptidase, Cyanogen Bromide, Iodobenzoate Benzoate, Clostripain, Trypsin R, AspN, Staph Protease
  ~351~ QQIEDSTSDY ~360~           1185.17     3.5    Trypsin, Chymotrypsin, Proline Endopeptidase, Cyanogen Bromide, Iodobenzoate Benzoate, Clostripain, Trypsin R, Staph Protease, Trypsin K
  ~385~ TEVEMKEKR ~393~            1149.33     5.9    Chymotrypsin, Proline Endopeptidase, Iodobenzoate Benzoate, Clostripain, Trypsin K
  ~453~ QIVENAGEEPSVVVNTVK ~470~   1912.13     4.2    Trypsin, Chymotrypsin, Cyanogen Bromide, Iodobenzoate Benzoate, Clostripain, Trypsin R, Trypsin K, AspN
  ~526~ DDKMDLGA ~534~             863.94      3.9    Chymotrypsin, Proline Endopeptidase, Iodose Benzoate, Clostripain, Trypsin R, Staph Protease

  T-cell epitopes                  Mass(Da)   pI                                                                                                                                               Undigested enzyme
  -------------------------------- ---------- ------------------------------------------------------------------------------------------------------------------------------------------------ ----------------------------------------------------------------------------------------------------------------
  ~160~ KLIAEAM~166~               774.9      6                                                                                                                                                Chymotrypsin, Proline Endopeptidase, Cyanogen Bromide, Iodobenzoate Benzoate, Clostripain, Trypsin R, AspN
  ~205~ INKPETGSVELENPYILL ~222~   2029.32    4.25                                                                                                                                             Trypsin, Cyanogen Bromide, Iodobenzoate Benzoate, Clostripain, Trypsin R, Trypsin K, AspN
  ~279~ PGFGDRR ~285~              803.88     10.0                                                                                                                                             Cyanogen Bromide, Iodobenzoate Benzoate, Elastase, Trypsin K, AspN, Staph Protease
  ~385~ TEVEMKEKRAR ~395~          1376.59    8.26                                                                                                                                             Chymotrypsin, Proline Endopeptidase, Iodobenzoate Benzoate, Clostripain,Trypsin.
  9.8                                                                                                                                                                                          
  ~418~ ALVRVAAALTALT ~430~        1269.55    9.7                                                                                                                                              Chymotrypsin, Proline Endopeptidase, Cyanogen Bromide, Iodobenzoate Benzoate, Staph Protease, Trypsin K, AspN.
  ~470~ KGGKGNY ~476~              722.80     Chymotrypsin, Proline Endopeptidase, Cyanogen Bromide, Iodobenzoate Benzoate, Staph Protease, Trypsin R, Proline Endopeptidase, AspN, Elastase   

The full length of candidate protein was identified as an antigen by VaxiJen 2.0 server (threshold 0.5) with score 0.52. Also, the antigenicity of the final B and T-cell predicted epitopes was shown in [Table 5](#T5){ref-type="table"}. Furthermore, the results of VaxiJen 2.0 analysis indicated that six B-cell epitopes and five T-cell epitopes had antigenic ability.

###### 

The antigenicity of predicted epitopes

  Final B-cell epitope             score                             Final T-cell epitope             score
  -------------------------------- --------------------------------- -------------------------------- ---------------------------------
  ~30~ TLGPKGRNVVL ~40~            -0.03[\*](#t5n1){ref-type="fn"}   ~160~ KLIAEAM ~166~              0\. 3[\*](#t5n1){ref-type="fn"}
  ~150~ ISANSDETVGKLIAEAM ~166~    0.75                              ~205~ INKPETGSVELENPYILL ~222~   1.1
  ~220~ ILLVDKKISNI ~230~          0.13[\*](#t5n1){ref-type="fn"}    ~279~ PGFGDRR ~285~              1.95
  ~270~ IVKVAAVKAP ~279~           0.88                              ~351~ QQIEDSTSDYD ~361~          0.88
  ~351~ QQIEDSTSDY ~360~           0.85                              ~385~ TEVEMKEKRAR ~395~          2.03
  ~385~ TEVEMKEKR ~393~            1.95                              ~418~ ALVRVAAALTALT ~430~        0.3[\*](#t5n1){ref-type="fn"}
  ~453~ QIVENAGEEPSVVVNTVK ~470~   0.53                              ~470~ KGGKGNY ~476~              2.4
  ~526~ DDKMDLGA ~534~             0.7                                                                

Probable Non-Antigen

According to the final B and T-cell predicted epitopes, common epitopes with the highest vaxiJen score for GroEL antigen were selected ([Figure 5](#F5){ref-type="fig"} and [Table 6](#T6){ref-type="table"}). These epitopes may be useful for developing subunit vaccines.

![Schematic predicted epitopes for synthetize (\* Start codon; \# Stop codon)](IJBMS-18-499-g005){#F5}

###### 

Common epitopes with the highest score

  Final common epitopes          Score
  ------------------------------ -------
  ~150~ ISANSDETVGK ~160~        1.95
  ~270~ IVKVAAVKAPGFGDRR ~285~   0.92
  ~351~ QQIEDSTSDYD ~361~        0.88
  ~385~ TEVEMKEKRAR ~395~        2.03

After the antigenicity test of the final B and T-cell predicted epitopes, the 3D structure of predicted epitopes with antigenic ability were illustrated using 3D Ligand Site server ([Figure 6](#F6){ref-type="fig"}). 3D structure analysis also showed that all common predicted epitopes were located on the outside of the GroEL antigen molecule.

![Common predicted epitopes: 150-160, 270-285, 351-361 and 385-395 shown by red, green, blue and yellow colors, respectively](IJBMS-18-499-g006){#F6}

Discussion {#sec1-4}
==========

Several studies predicted epitopes of desired antigen by computational approaches and used these results in experimental studies with the aim of epitope based vaccine design ([@ref21], [@ref17]). In this study, GroEl gene of *B. melitensis* Rev l was candidate for cloning, molecular analysis and epitope prediction. Results showed that all candidate genes successfully cloned, and molecular analysis revealed that GroEL sequence of *B. melitensis* Rev l is nearly similar to species other than *Brucella* spp. Because this gene exists in different species and is nearly similar in most of them, although unexpected, had similarity with other *Brucella* species. Therefore, this gene can be a good candidate for stimulation of immune response against different bacterium species. Comprehensive bioinformatics analyses were conducted on the candidate antigen by online B and T-cell epitope prediction servers. To validate the results of our bioinformatics approaches, we compared computational outputs obtained from different antigens with their experimental results. The experimentally achieved epitopes successfully conformed to the predicted bioinformatics analysis ([Table 2](#T2){ref-type="table"}).

To prevent degradation of peptide during antigen processing, epitope should lack proteasomal cleavage site ([@ref19]). In order to, the B and T-cell predicted epitope was analyzed for enzymatic degradation. The proposed epitopes in this study have no proteasomal digestion sites for most cell dominant enzymes ([Table 4](#T4){ref-type="table"}). The results of epitope prediction showed eight B-cell and seven T-cell epitopes for this antigen. After, examining predicted epitopes according to the proteasomal digestion sites and antigenicity ability, four (150-160, 270-285, 351-361 and 385-395) epitopes became candidates for future research.

Conclusion {#sec1-5}
==========

The phylogenetic analysis showed that the GroEL sequence had near homology with other species instead of other *Brucella* spp. According to the antigenic ability and proteasomal cleavage sites, four (150-160, 270-285,351-361 and 385-395) common epitopes were predicted for GroEL gene. Bioinformatics analysis showed that these regions had proper epitope characterization and thus may be useful for stimulation of cell-mediated and humoral immunity systems. Furthermore, *in vitro* synthesis of determined peptides and experimental validation are essential for using predicted epitope as an effective vaccine against the *Brucella* pathogen and diagnostic kits; our laboratory has already initiated research in this direction.
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